SCHEMBL24175877

SCHEMBL24175877

CC(C)C(C)C(C)c1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.52
FFAR2 O15552 2/20 0.42
TSHR P16473 2/20 0.42
MAPK1 P28482 2/20 0.42
HIF1A Q16665 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
LMNA P02545 2/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
CYP2A6 P11509 1/20 0.40
AOC3 Q16853 2/20 0.39
BRD4 O60885 1/20 0.39
CYP19A1 P11511 3/20 0.38
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38
SLC6A2 P23975 3/20 0.37
SLC6A3 Q01959 3/20 0.37
SLC6A4 P31645 2/20 0.37
PRCP P42785 1/20 0.36
AKT1 P31749 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16687360 0.84 ADRB2 (0.56) ADRB2FFAR2TSHRMAPK1HIF1A
SCHEMBL19577176 0.84 ADRB2 (0.56) ADRB2FFAR2TSHRMAPK1HIF1A
SCHEMBL436846 0.84 ADRB2 (0.56) ADRB2FFAR2TSHRMAPK1HIF1A
SCHEMBL11949354 0.84 ADRB2 (0.62) ADRB2FFAR2TSHRMAPK1HIF1A
SCHEMBL19865621 0.78 ADRB2 (0.50) ADRB2FFAR2TSHRMAPK1HIF1A
SCHEMBL197810 0.75 ADRB2 (0.65) ADRB2FFAR2TSHRMAPK1HIF1A
SCHEMBL19262099 0.75 AOC3 (0.39) AOC3IDO1TDO2SLC6A2SLC6A3
SCHEMBL23178021 0.75 MEN1 (0.40) ADRB2TSHRMAPK1HIF1ATDP1
SCHEMBL683625 0.74 TSHR (0.59) ADRB2FFAR2TSHRMAPK1HIF1A
SCHEMBL21939262 0.74 ADRB2 (0.56) ADRB2FFAR2TSHRMAPK1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584773-B2 Phosphorous protecting groups and methods of preparation and use thereof AGILENT TECHNOLOGIES, INC. (US) 2023-02-21 US disclosed
US-20220002334-A1 PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF UNIVERSITY OF COLORADO BOULDER 2022-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002334-A1 PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF POLN, POLRMT, NUDT21 ADRB2 4850/4885FFAR2 4609/4885TSHR 3949/4885
US-11584773-B2 Phosphorous protecting groups and methods of preparation and use thereof POLN, POLRMT, NUDT21 ADRB2 4850/4885FFAR2 4609/4885TSHR 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.